Acadia Healthcare Company, Inc. (ACHC) research
Acadia Healthcare Company, Inc.- Sector
- Health Care
- Last price
- $28.87
- As of
Kresmion compiles this page from ACHC's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Acadia Healthcare Company, Inc. (ACHC): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-25.
As of . Source: SEC EDGAR filings for ACHC. Method and limitations.
Share the ACHC intelligence card
See the full ACHC dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ACHC on one page. Preview it with sample data, then open it live with a free account.
Preview the ACHC dossierActive signals for ACHC
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +168% to ACHC (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +53% to ACHC (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +7494% to ACHC (2026Q2)
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 61% of ACHC (2026Q2)
- highINSTITUTIONAL_EXIT
Bridgewater Associates, LP cut 63% of ACHC (2026Q2)
FREE, NO ACCOUNT
Every signal on ACHC, as it fires
You are seeing 5 of 10 signals recorded on ACHC since 2026-06-21.
The five above all landed on 2026-08-16. The other 5 were recorded on 2 other days. 5 of the 10 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in ACHC (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 00404A109 · 2026Q2 | $78.7M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 00404A109 · 2026Q2 | $5.4M | 0.00% | , |
| Bridgewater Associates, LPCUSIP 00404A109 · 2026Q2 | $1.9M | 0.01% | , |
| D. E. Shaw & Co., Inc.CUSIP 00404A109 · 2026Q2 | $1.6M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, ACHC
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
ACHC against its peers
ACHC's net margin of -33.3% ranks in the 2nd percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.
| Metric | ACHC | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 3.3B USD | 1.4B USD | 83 | 25 |
| Gross margin | n/a | 54.6% | n/a | 20 |
| Operating margin | n/a | 5.3% | n/a | 24 |
| Net margin | -33.3% | 1.1% | 2 | 25 |
| Return on equity | -56.6% | 2.3% | 6 | 24 |
| P / E | n/a | 32.1x | n/a | 13 |
Peers (25): BKD, PRVA, AVAH, ATRC, TMDX, WGS, MD, SEM, INSP, PGNY, LMAT, NVCR, XRAY, OPCH, CRVL, IRTC, NVST, ALHC, ATEC, LIVN, OMCL, ITGR, CERT, AMN, CNMD. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (ACHC: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow ACHC on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to ACHC for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.